Boston Scientific (BSX)

Operating Income Growth

51.31%

TTM · Period ending:

BSX logo

BSX Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported51.31%
BSX TTM Operating Income YoY % (31.59% → 51.31%)
High-resolution chart · PNG

BSX operating income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Boston Scientific Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
51.3096%
42.7047%
49.6232%
27.8689%
18.7874%
25.7464%
21.6315%
26.5316%
26.9367%
21.5676%
18.3939%
11.9935%
7.7469%
1.8211%
4.1243%
24.4788%
40.2448%
154.0136%
195.9866%
78.5114%
35.0207%
-49.6575%
-64.1056%
-50.4462%
-42.8909%
-14.6698%
-4.1978%
-4.4343%
-1.6821%
2.3325%
14.1825%
25.9127%
27.045%
166.242%
148.4502%
5,720.8333%
322.0949%
1,182.7586%
287.4618%
-52.9412%
-247.5845%
-146.0317%
-209.3645%
-84.0125%
15.6425%
-80.5255%
149.1667%
195.3704%
155.0769%
115.1098%
103.1949%
102.9181%
77.3677%
-651.094%
-528.2782%
-450.8057%
-353.7102%
-30.9947%
233.689%
147.2036%
152.8725%
153.6958%
-9.3333%
-25.14%
-1.8069%
-1.0602%
60.1594%
-471.3098%
-787.2549%
-833.2155%
-9,940%
-31.1874%
-70.6052%
108.9444%
99.4914%
125.2529%
131.555%
-432.3529%
-404.6488%
-374.8759%
-293.9447%
-47.7784%
-38.5006%
-20.4581%
57.3543%
126.1787%
125.825%
92.4012%
47.8796%
25.9375%
14.2623%
17.2906%
75.2998%
245.9459%
510%
331.5385%
116.0622%
-65.4206%
-85.1852%
-82.2161%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.